Carnival (CCL:NYS) Fundamental Valuation Report

Fundamental Valuation Report

Carnival(CCL:NYS)

Consumer Cyclical:Leisure

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$56.96 (USD) 07/02/2019

Weighted Valuation
$67.93 (USD)

Overall Rating
Undervalued by 19.3%

Valuation Models Analyst Consensus: $73.23 (USD)
(in order of importance) Adjusted Book Value: $59.97 (USD)
Valuation Methods This company is:
Cash Flow: Undervalued on a Cash Flow Valuation
Comparable Company: Overvalued on a Comparable Valuation
Asset: Undervalued on an Asset Valuation

Company Overview (CCL:NYS USD)

Price 56.96
Range 56.43 – 58.01
52 week 46.21 – 69.92
Open 57.54
Vol / Avg. 3.9M/3.93M
Mkt cap 40.93B
P/E 12.83
Div/yield 1.95/0.03
EPS 4.44
Shares 718.6M
Beta 1.25

Company Description

Carnival is the largest global cruise company, with more than 100 ships on the seas. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe; and P&O Cruises in Australia. Carnival also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival’s brands attract more than 12.5 million guests annually.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for CCL:NYS

Using a discounted cash flow model we generated an intrinsic value of $75.24 (USD) for CCL:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

CCL:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $75.24 1% 5% 1% 5%
WACC (or Ke) 10.16 $90.04 $64.08
Terminal Growth Rate 3.00 $65.17 $88.59
Tax Rate 0.02 $80.69 $70.23
Cash Flow 7,680,813,000 $68.65 $81.83
Capital Expenditures -2,830,000,000 $73.21 $77.28
Long Term Debt 9,393,000,000 $75.90 $74.59

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $0.00 (USD) for CCL:NYS. We also generated a valuation of $44.19 (USD) using other metrics and comparables.
The comparable companies were Expedia Group (EXPE:NAS), Hasbro (HAS:NAS), Norwegian Cruise Line (NCLH:NYS) and Royal Caribbean Cruises (RCL:NYS).

Company CCL:NYS End Date Value
Earnings/Share $4.44 (USD)
Book Value/Share $0.00 (USD)
Sales/Share $0.00 (USD)
Cash Flow/Share $0.00 (USD)
EBITDA/Share $7.63 (USD)
Price Based on Comps Adjustment Factor (%)
$0.00 (USD) -41.8
$0.00 (USD) -78.8
$0.00 (USD) -2.1
($14.54) (USD) -37.8
$0.00 (USD) -3.8
CCL:NYS Ratios Used Average Values EXPE:NAS HAS:NAS NCLH:NYS RCL:NYS
0.00 PE Ratio 14.02 0.00 0.00 0.00 14.02
0.00 PB Ratio 2.26 0.00 0.00 0.00 2.26
0.00 PS Ratio 2.68 0.00 0.00 0.00 2.68
0.00 PCF Ratio 8.02 0.00 0.00 0.00 8.02
0.00 EV to EBITDA 11.18 0.00 0.00 0.00 11.18

Multiples

Using a multiples approach we generated a valuation of  $84.59 (USD) for CCL:NYS

Company CCL:NYS End Date Value
Earnings/Share $4.44 (USD)
Book Value/Share $0.00 (USD)
Sales/Share $0.00 (USD)
Cash Flow/Share $0.00 (USD)
EBITDA/Share $7.63 (USD)
Price Based on Comps Adjustment Factor
$79.89 (USD) 0
$0.00 (USD) 0
$0.00 (USD) 0
$0.00 (USD) 0
$89.30 (USD) 0
Ratios Ratio Average
PE Ratio 17.99
PB Ratio 1.73
PS Ratio 2.43
PCF Ratio 8.76
EV to EBITDA 11.70

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  CCL:NYS for the last 10 years was  1.71

We ran the Adjusted Book Value for  CCL:NYS and generated a book value of  $35.12 (USD)
By multiplying these we get an adjusted valuation of  $59.97 (USD)

Analyst Data

In the Stockcalc database there are 3 analysts that provide a valuation for CCL:NYS. The 3 analysts have a concensus valuation for CCL:NYS for 2019 of $73.23 (USD).

CCL:NYS Carnival

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
3 1 0 4.4000 Outperform 2019-2-6

Current Price: 56.96 USD

Analyst Consensus
USD Millions 2019 2020 2021
Mean EPS 4.83 5.38 6.72
# EPS Analysts 5 5 1
Mean Revenue 19,713.80 21,409.60 23,522.20
# Revenue Analysts 3 3 1
Mean Target Price 73.23
Mean Cash Flow 8.19 9.19 10.58
Mean EBITDA 5,803.00 6,396.90 7,457.10
Mean Net Income 3,322.50 3,720.60 4,517.00
Mean Debt Outstanding 11,869.20 12,350.40 13,050.40
Mean Tax Rate
Mean Growth Rate 10.89
Mean Capital Expenditure 6,212.70 5,402.90 4,495.60

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


Carnival (CCL:NYS) Fundamental Valuation Report

Fundamental Valuation Report

Carnival(CCL:NYS)

Consumer Cyclical:Leisure

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$58.31 (USD) 06/02/2019

Weighted Valuation
$67.92 (USD)

Overall Rating
Undervalued by 16.5%

Valuation Models Analyst Consensus: $73.23 (USD)
(in order of importance) Adjusted Book Value: $59.96 (USD)
Valuation Methods This company is:
Cash Flow: Undervalued on a Cash Flow Valuation
Comparable Company: Overvalued on a Comparable Valuation
Asset: Fairly valued on an Asset Valuation

Company Overview (CCL:NYS USD)

Price 58.31
Range 58.06 – 58.57
52 week 46.21 – 69.92
Open 58.55
Vol / Avg. 3.29M/3.94M
Mkt cap 41.9B
P/E 13.13
Div/yield 1.95/0.03
EPS 4.44
Shares 718.6M
Beta 1.25

Company Description

Carnival is the largest global cruise company, with more than 100 ships on the seas. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe; and P&O Cruises in Australia. Carnival also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival’s brands attract more than 12.5 million guests annually.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for CCL:NYS

Using a discounted cash flow model we generated an intrinsic value of $75.24 (USD) for CCL:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

CCL:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $75.24 1% 5% 1% 5%
WACC (or Ke) 10.16 $90.04 $64.08
Terminal Growth Rate 3.00 $65.17 $88.59
Tax Rate 0.02 $80.69 $70.23
Cash Flow 7,680,813,000 $68.65 $81.83
Capital Expenditures -2,830,000,000 $73.21 $77.28
Long Term Debt 9,393,000,000 $75.90 $74.59

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $0.00 (USD) for CCL:NYS. We also generated a valuation of $44.35 (USD) using other metrics and comparables.
The comparable companies were Expedia Group (EXPE:NAS), Hasbro (HAS:NAS), Norwegian Cruise Line (NCLH:NYS) and Royal Caribbean Cruises (RCL:NYS).

Company CCL:NYS End Date Value
Earnings/Share $4.44 (USD)
Book Value/Share $0.00 (USD)
Sales/Share $0.00 (USD)
Cash Flow/Share $0.00 (USD)
EBITDA/Share $7.63 (USD)
Price Based on Comps Adjustment Factor (%)
$0.00 (USD) -41.8
$0.00 (USD) -78.8
$0.00 (USD) -2.1
($14.54) (USD) -37.8
$0.00 (USD) -3.8
CCL:NYS Ratios Used Average Values EXPE:NAS HAS:NAS NCLH:NYS RCL:NYS
0.00 PE Ratio 14.02 0.00 0.00 0.00 14.02
0.00 PB Ratio 2.26 0.00 0.00 0.00 2.26
0.00 PS Ratio 2.68 0.00 0.00 0.00 2.68
0.00 PCF Ratio 8.02 0.00 0.00 0.00 8.02
0.00 EV to EBITDA 11.18 0.00 0.00 0.00 11.18

Multiples

Using a multiples approach we generated a valuation of  $84.59 (USD) for CCL:NYS

Company CCL:NYS End Date Value
Earnings/Share $4.44 (USD)
Book Value/Share $0.00 (USD)
Sales/Share $0.00 (USD)
Cash Flow/Share $0.00 (USD)
EBITDA/Share $7.63 (USD)
Price Based on Comps Adjustment Factor
$79.89 (USD) 0
$0.00 (USD) 0
$0.00 (USD) 0
$0.00 (USD) 0
$89.30 (USD) 0
Ratios Ratio Average
PE Ratio 17.99
PB Ratio 1.73
PS Ratio 2.43
PCF Ratio 8.76
EV to EBITDA 11.70

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  CCL:NYS for the last 10 years was  1.71

We ran the Adjusted Book Value for  CCL:NYS and generated a book value of  $35.12 (USD)
By multiplying these we get an adjusted valuation of  $59.96 (USD)

Analyst Data

In the Stockcalc database there are 3 analysts that provide a valuation for CCL:NYS. The 3 analysts have a concensus valuation for CCL:NYS for 2019 of $73.23 (USD).

CCL:NYS Carnival

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
3 1 0 4.4000 Outperform 2019-2-5

Current Price: 58.31 USD

Analyst Consensus
USD Millions 2019 2020 2021
Mean EPS 4.83 5.38 6.72
# EPS Analysts 5 5 1
Mean Revenue 19,713.80 21,409.60 23,522.20
# Revenue Analysts 3 3 1
Mean Target Price 73.23
Mean Cash Flow 8.19 9.19 10.58
Mean EBITDA 5,803.00 6,396.90 7,457.10
Mean Net Income 3,322.50 3,720.60 4,517.00
Mean Debt Outstanding 11,869.20 12,350.40 13,050.40
Mean Tax Rate
Mean Growth Rate 10.89
Mean Capital Expenditure 6,212.70 5,402.90 4,495.60

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


Carnival (CCL:NYS) Fundamental Valuation Report

Fundamental Valuation Report

Carnival(CCL:NYS)

Consumer Cyclical:Leisure

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$56.26 (USD) 29/01/2019

Weighted Valuation
$63.39 (USD)

Overall Rating
Undervalued by 12.7%

Valuation Models Analyst Consensus: $73.23 (USD)
(in order of importance) Comparables: $50.37 (USD)
Adjusted Book Value: $59.92 (USD)
Valuation Methods This company is:
Cash Flow: Undervalued on a Cash Flow Valuation
Comparable Company: Overvalued on a Comparable Valuation
Asset: Undervalued on an Asset Valuation

Company Overview (CCL:NYS USD)

Price 56.26
Range 55.95 – 56.52
52 week 46.21 – 71.61
Open 56.49
Vol / Avg. 3.14M/4.36M
Mkt cap 40.43B
P/E 12.54
Div/yield 1.95/0.03
EPS 4.44
Shares 718.6M
Beta 1.15

Company Description

Carnival is the largest global cruise company, with more than 100 ships on the seas. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe; P&O Cruises in Australia; and Fathom, supporting impact travel. Carnival also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival’s brands attract more than 12.4 million guests annually.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for CCL:NYS

Using a discounted cash flow model we generated an intrinsic value of $85.06 (USD) for CCL:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

CCL:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $85.06 1% 5% 1% 5%
WACC (or Ke) 9.47 $103.52 $71.56
Terminal Growth Rate 3.00 $72.76 $101.87
Tax Rate 0.02 $91.03 $79.54
Cash Flow 7,680,813,000 $77.75 $92.37
Capital Expenditures -2,830,000,000 $82.77 $87.36
Long Term Debt 9,393,000,000 $85.72 $84.41

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $50.37 (USD) for CCL:NYS. We also generated a valuation of $48.00 (USD) using other metrics and comparables.
The comparable companies were Expedia Group (EXPE:NAS), Hasbro (HAS:NAS), Norwegian Cruise Line (NCLH:NYS) and Royal Caribbean Cruises (RCL:NYS).

Company CCL:NYS End Date Value
Earnings/Share $4.44 (USD)
Book Value/Share $35.12 (USD)
Sales/Share $26.59 (USD)
Cash Flow/Share $7.82 (USD)
EBITDA/Share $7.63 (USD)
Price Based on Comps Adjustment Factor (%)
$123.21 (USD) -41.8
$110.45 (USD) -78.8
$50.78 (USD) -2.1
$54.18 (USD) -37.8
$81.37 (USD) -3.8
CCL:NYS Ratios Used Average Values EXPE:NAS HAS:NAS NCLH:NYS RCL:NYS
11.10 PE Ratio 27.75 38.84 49.85 10.65 11.66
1.40 PB Ratio 3.14 3.83 5.45 1.50 1.80
1.85 PS Ratio 1.91 1.58 2.17 1.62 2.27
6.31 PCF Ratio 8.79 8.79 14.87 4.94 6.57
8.32 EV to EBITDA 10.66 10.29 13.63 8.89 9.85

Multiples

Using a multiples approach we generated a valuation of  $72.86 (USD) for CCL:NYS

Company CCL:NYS End Date Value
Earnings/Share $4.44 (USD)
Book Value/Share $35.12 (USD)
Sales/Share $26.59 (USD)
Cash Flow/Share $7.82 (USD)
EBITDA/Share $7.63 (USD)
Price Based on Comps Adjustment Factor
$80.40 (USD) 0
$60.82 (USD) 0
$64.84 (USD) 0
$68.67 (USD) 0
$89.56 (USD) 0
Ratios Ratio Average
PE Ratio 18.11
PB Ratio 1.73
PS Ratio 2.44
PCF Ratio 8.79
EV to EBITDA 11.74

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  CCL:NYS for the last 10 years was  1.71

We ran the Adjusted Book Value for  CCL:NYS and generated a book value of  $35.12 (USD)
By multiplying these we get an adjusted valuation of  $59.92 (USD)

Analyst Data

In the Stockcalc database there are 3 analysts that provide a valuation for CCL:NYS. The 3 analysts have a concensus valuation for CCL:NYS for 2019 of $73.23 (USD).

CCL:NYS Carnival

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
3 1 0 4.4000 Outperform 2019-1-28

Current Price: 56.26 USD

Analyst Consensus
USD Millions 2019 2020 2021
Mean EPS 4.83 5.44 6.72
# EPS Analysts 5 4 1
Mean Revenue 19,713.80 21,468.10 23,522.20
# Revenue Analysts 3 2 1
Mean Target Price 73.23
Mean Cash Flow 8.19 9.33 10.58
Mean EBITDA 5,803.00 6,461.10 7,457.10
Mean Net Income 3,322.40 3,799.60 4,517.80
Mean Debt Outstanding 11,870.80 12,352.80 13,056.30
Mean Tax Rate
Mean Growth Rate 12.11
Mean Capital Expenditure 6,213.40 5,154.40 4,495.60

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


The Madison Square Garden (MSG:NYS) Fundamental Valuation Report

Fundamental Valuation Report

The Madison Square Garden(MSG:NYS)

Consumer Cyclical:Leisure

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$272.50 (USD) 08/11/2018

Weighted Valuation
$306.00 (USD)

Overall Rating
Undervalued by 12.3%

Valuation Models Analyst Consensus: $360.00 (USD)
(in order of importance) Comparables: $225.00 (USD)
Multiples: $305.97 (USD)
Valuation Methods This company is:
Cash Flow: Overvalued on a Cash Flow Valuation
Comparable Company: Overvalued on a Comparable Valuation
Asset: Overvalued on an Asset Valuation

Company Overview (MSG:NYS USD)

Price 272.50
Range 271.28 – 279.57
52 week 207.90 – 327.30
Open 276.93
Vol / Avg. 156744/333882
Mkt cap 6.47B
P/E 53.96
Div/yield 0.00/0.00
EPS 5.94
Shares 23.75M
Beta 0.00

Company Description

The Madison Square Garden Co is a live sports and entertainment company operating in New York, USA. Its segments include MSG Sports and MSG Entertainment. The MSG Sports segment operates Madison’s professional sports franchises, namely New York Knicks, New York Rangers, New York Liberty the Hartford Wolf Pack of American Hockey League, and the Westchester Knicks. The MSG Entertainment segment comprises live entertainment events – including concerts, family shows, performing arts and special events at venues which include Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, the Beacon Theatre, the Forum, The Chicago Theatre and the Wang Theatre. Revenues are generated from the sale of tickets for events and distributions of league-wide television contracts.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for MSG:NYS

Using a discounted cash flow model we generated an intrinsic value of $162.13 (USD) for MSG:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

MSG:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $162.13 1% 5% 1% 5%
WACC (or Ke) 8.07 $202.28 $135.22
Terminal Growth Rate 3.00 $137.89 $198.29
Tax Rate 0.27 $171.08 $153.19
Cash Flow 237,790,051 $155.62 $168.65
Capital Expenditures 864,200 $162.16 $162.11
Long Term Debt 0 $162.13 $162.13

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $225.00 (USD) for MSG:NYS. We also generated a valuation of $308.53 (USD) using other metrics and comparables.
The comparable companies were Expedia Group (EXPE:NAS), Hasbro (HAS:NAS), International Speedway (ISCA:NAS), SeaWorld Entertainment (SEAS:NYS) and TripAdvisor (TRIP:NAS).

Company MSG:NYS End Date Value
Earnings/Share $5.05 (USD)
Book Value/Share $106.79 (USD)
Sales/Share $65.38 (USD)
Cash Flow/Share $9.25 (USD)
EBITDA/Share $6.51 (USD)
Price Based on Comps Adjustment Factor (%)
$177.73 (USD) 0.0
$546.05 (USD) 0.0
$166.67 (USD) 0.0
$136.28 (USD) 0.0
$98.29 (USD) 0.0
MSG:NYS Ratios Used Average Values EXPE:NAS HAS:NAS ISCA:NAS SEAS:NYS TRIP:NAS
46.57 PE Ratio 35.20 43.25 56.26 6.07 0.00 0.00
2.59 PB Ratio 5.11 4.26 6.57 1.01 8.40 5.33
4.23 PS Ratio 2.55 1.76 2.33 2.35 1.72 4.60
29.90 PCF Ratio 15.21 9.79 19.46 7.32 9.75 29.72
35.05 EV to EBITDA 15.10 11.44 14.02 7.05 14.97 28.01

Multiples

Using a multiples approach we generated a valuation of  $305.97 (USD) for MSG:NYS

Company MSG:NYS End Date Value
Earnings/Share $5.05 (USD)
Book Value/Share $106.79 (USD)
Sales/Share $65.38 (USD)
Cash Flow/Share $9.25 (USD)
EBITDA/Share $6.51 (USD)
Price Based on Comps Adjustment Factor
$419.81 (USD) 0
$199.88 (USD) 0
$252.97 (USD) 0
$313.81 (USD) 0
$343.38 (USD) 0
Ratios Ratio Average
PE Ratio 83.13
PB Ratio 1.87
PS Ratio 3.87
PCF Ratio 33.91
EV to EBITDA 52.74

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  MSG:NYS for the last 3 years was  1.88

We ran the Adjusted Book Value for  MSG:NYS and generated a book value of  $106.91 (USD)
By multiplying these we get an adjusted valuation of  $200.74 (USD)

Analyst Data

In the Stockcalc database there are 1 analysts that provide a valuation for MSG:NYS. The 1 analysts have a concensus valuation for MSG:NYS for 2019 of $360.00 (USD).

MSG:NYS The Madison Square Garden

No analyst recommendation
Current Price: not available

No analyst consensus

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


Celgene (CELG:NAS) and Shire (SHPG:NAS) Are Undervalued

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Undervalued Stocks on NASDAQ

Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.

In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.

There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Target Year Close Price Target Price Mean Currency Target Price # of Estimates
CELG Celgene Corp 2018 100.970000 141.5714 USD 7
SHPG Shire PLC 2018 147.630000 228.5090 USD 5
CHKP Check Point Software Technologies Ltd 2018 117.710000 181.8750 USD 8
EXPE Expedia Inc 2018 124.660000 157.8000 USD 5
DXCM DexCom Inc 2018 44.970000 82.5000 USD 4
AYTU Aytu BioScience Inc 2018 3.296000 50.0000 USD 1
EQIX Equinix Inc 2018 463.500000 506.4000 USD 5
ICPT Intercept Pharmaceuticals Inc 2018 61.630000 142.2500 USD 4
ALXN Alexion Pharmaceuticals Inc 2018 119.660000 156.8000 USD 5
TSRO Tesaro Inc 2018 115.770000 151.6000 USD 5
SINA SINA Corp 2018 107.650000 142.0000 USD 1
ULTA Ulta Beauty Inc 2019 201.790000 265.3333 USD 3
ADMS Adamas Pharmaceuticals Inc 2018 24.660000 85.0000 USD 1
COHR Coherent Inc 2018 262.710000 309.6667 USD 3
PCLN The Priceline Group Inc 2018 1911.960000 2070.0000 USD 5
GOOG Alphabet Inc 2018 1016.640000 1164.0000 USD 10
AMZN Amazon.com Inc 2018 1105.280000 1246.7270 USD 11
GOOGL Alphabet Inc 2018 1033.040000 1164.0000 USD 10
REGN Regeneron Pharmaceuticals Inc 2018 402.620000 516.0000 USD 5
CHTR Charter Communications Inc 2018 334.170000 429.5000 USD 4
ATRA Atara Biotherapeutics Inc 2018 14.200000 47.0000 USD 1
TNDM Tandem Diabetes Care Inc 2018 2.470000 35.0000 USD 2
DISH DISH Network Corp 2018 48.540000 80.0000 USD 4
RGLD Royal Gold Inc 2018 84.110000 122.2654 CAD 2
JAZZ Jazz Pharmaceuticals PLC 2018 141.530000 179.5000 USD 6

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

CELG:NAS Celgene

http://www.celgene.com
Celgene has 7132 employees and is headquartered in United States.
Celgene Corp is a biotech company that discovers, develops, and commercializes therapies designed to treat cancer and immune-inflammatory related diseases. Its registered brands are Abraxane, Istodax, Otezla, Pomalyst, Revlimid, Thalomid, Vidaza.

SHPG:NAS Shire

http://www.shire.com
Shire has 23906 employees and is headquartered in Ireland.
Shire PLC is a biotechnology company focused mainly in the research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines for patients with rare diseases and other select conditions.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

PPG Industries (PPG:NYS) and Expedia (EXPE:NAS) Upgraded

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com


I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Upgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been upgraded by at least one analyst in the last few days.

Why Do Companies Get Upgraded?

Companies can get upgraded for a number of reasons, but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
PPG PPG Industries Inc 6 0 3 0 0 0 4.3333 4.1111 Outperform
BIP Brookfield Infrastructure Partners LP 1 0 0 0 0 0 5.0000 4.5000 Buy
IRM Iron Mountain Inc 0 1 0 0 1 0 2.5000 2.0000 Underperform
AAP Advance Auto Parts Inc 6 0 3 0 0 0 4.3333 4.2222 Outperform
BPY Brookfield Property Partners LP 3 0 0 0 0 0 5.0000 4.6667 Buy
MTDR Matador Resources Co 1 0 1 0 0 0 4.0000 3.6667 Outperform
MORE Monogram Residential Trust Inc 1 0 1 0 0 0 4.0000 3.0000 Outperform
RFP Resolute Forest Products Inc 0 0 1 0 0 0 3.0000 2.2000 Hold
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
BIP.UN Brookfield Infrastructure Partners LP 1 0 0 0 0 0 5.0000 4.5000 Buy
BPY.UN Brookfield Property Partners LP 3 0 0 0 0 0 5.0000 4.6667 Buy
EDV Endeavour Mining Corp 1 0 0 0 0 0 5.0000 4.5714 Buy
ORL Orocobre Ltd 1 0 0 0 0 0 5.0000 4.3333 Buy
RFP Resolute Forest Products Inc 0 0 1 0 0 0 3.0000 2.2000 Hold
PRU Perseus Mining Ltd 1 0 0 0 0 0 5.0000 4.2500 Buy
PMTS CPI Card Group Inc 1 0 0 0 0 0 5.0000 3.0000 Buy
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
EXPE Expedia Inc 7 1 0 0 0 0 4.8750 4.8571 Buy
ORLY O’Reilly Automotive Inc 4 1 3 0 0 0 4.1250 4.0000 Outperform
BNFT Benefitfocus Inc 3 0 1 0 0 0 4.5000 4.3333 Outperform
ABDC Alcentra Capital Corp 1 0 1 0 0 0 4.0000 3.0000 Outperform
PMTS CPI Card Group Inc 1 0 0 0 0 0 5.0000 3.0000 Buy

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

PPG:NYS PPG Industries

http://www.ppg.com
PPG Industries has 47000 employees and is headquartered in United States.
PPG Industries Inc is engaged in manufacturing and distributing coatings, specialty materials and glass products. It sells its products to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets.

EXPE:NAS Expedia

http://www.expedia.com
Expedia has 20075 employees and is headquartered in United States.
Expedia Inc is an online travel company. It offers holiday packages, rental cars, cruises, as well as destination services and activities.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

Citigroup (C:NYS) and Regeneron Pharmaceuticals (REGN:NAS) Upgraded

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com/registration2.aspx

I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Upgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been upgraded by at least one analyst in the last few days.

Why Do Companies Get Upgraded?

Companies can get upgraded for a number of reasons, but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
C Citigroup Inc 4 1 3 0 2 0 3.5000 3.3000 Hold
HUM Humana Inc 3 0 4 0 1 0 3.5000 3.2500 Hold
TYL Tyler Technologies Inc 2 0 0 0 0 0 5.0000 4.3333 Buy
NRZ New Residential Investment Corp 1 0 0 0 0 0 5.0000 4.0000 Buy
AN AutoNation Inc 2 0 4 0 1 0 3.2857 3.0000 Hold
YELP Yelp Inc 3 0 4 0 2 0 3.2222 3.2000 Hold
EGO Eldorado Gold Corp 5 3 2 0 0 0 4.3000 4.2000 Outperform
AHP Ashford Hospitality Prime Inc 1 0 1 0 0 0 4.0000 3.0000 Outperform
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
VSN Veresen Inc 3 0 3 0 1 0 3.5714 3.2500 Outperform
ELD Eldorado Gold Corp 5 3 2 0 0 0 4.3000 4.2000 Outperform
AD Alaris Royalty Corp 3 2 3 0 0 0 4.0000 3.8889 Outperform
SWY Stornoway Diamond Corp 2 1 1 0 0 0 4.2500 4.2000 Outperform
RAY.A Stingray Digital Group Inc 3 0 0 0 0 0 5.0000 4.3333 Buy
DEE Delphi Energy Corp 3 2 0 0 0 0 4.6000 4.5000 Buy
RAY.B Stingray Digital Group Inc 3 0 0 0 0 0 5.0000 4.3333 Buy
TSX Venture Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
TVL Traverse Energy Ltd 1 0 0 0 0 0 5.0000 4.0000 Buy
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
REGN Regeneron Pharmaceuticals Inc 6 1 1 0 0 0 4.6250 4.4444 Buy
EXPE Expedia Inc 6 1 0 0 0 0 4.8571 4.6250 Buy
CERN Cerner Corp 3 0 5 0 0 0 3.7500 3.6667 Outperform
AMD Advanced Micro Devices Inc 1 0 5 0 2 0 2.7500 2.7143 Hold
TRMB Trimble Inc 1 0 1 0 0 0 4.0000 3.6667 Outperform
CAVM Cavium Inc 4 0 3 0 0 0 4.1429 4.0000 Outperform
IRBT iRobot Corp 0 0 1 0 0 0 3.0000 2.0000 Hold
FBNC First Bancorp 1 0 2 0 0 0 3.6667 3.0000 Outperform

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

C:NYS Citigroup

http://www.citigroup.com
Citigroup has 219000 employees and is headquartered in United States.
Citigroup Inc is a financial-services company with business spanning more than 100 countries. Its core business is providing banking services, investment banking, cash management, and various other products and services.

REGN:NAS Regeneron Pharmaceuticals

http://www.regeneron.com
Regeneron Pharmaceuticals has 5400 employees and is headquartered in United States.
Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

Alphabet (GOOG:NAS) and Gilead Sciences (GILD:NAS) Are Undervalued

I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Undervalued Stocks on NASDAQ

Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.

In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.

There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Target Year Close Price Target Price Mean Currency Target Price # of Estimates
GOOGL Alphabet Inc 2017 840.030000 981.8333 USD 12
GOOG Alphabet Inc 2017 820.450000 981.8333 USD 12
AMZN Amazon.com Inc 2017 836.390000 949.3636 USD 11
GILD Gilead Sciences Inc 2017 67.550000 98.6667 USD 3
PCLN The Priceline Group Inc 2017 1637.290000 1751.4290 USD 7
BIIB Biogen Inc 2017 285.140000 333.0000 USD 6
SHPG Shire PLC 2017 172.320000 230.0461 USD 2
REGN Regeneron Pharmaceuticals Inc 2017 376.520000 458.0000 USD 4
ALXN Alexion Pharmaceuticals Inc 2017 129.500000 161.0000 USD 3
ISRG Intuitive Surgical Inc 2017 714.920000 761.6667 USD 3
EQIX Equinix Inc 2017 382.640000 420.0000 USD 2
ORLY O’Reilly Automotive Inc 2017 269.520000 308.2000 USD 5
EXPE Expedia Inc 2017 119.670000 150.5714 USD 7
ULTA Ulta Beauty Inc 2018 271.460000 305.7500 USD 4
ULTI The Ultimate Software Group Inc 2017 196.280000 239.5714 USD 7
LOGM LogMeIn Inc 2017 94.350000 125.0000 USD 1
RGLD Royal Gold Inc 2017 71.280000 116.8240 CAD 2
ICPT Intercept Pharmaceuticals Inc 2017 126.960000 190.8000 USD 5
ACIA Acacia Communications Inc 2017 65.710000 125.0000 USD 1
MSTR MicroStrategy Inc 2017 192.990000 225.5000 USD 2
SAGE Sage Therapeutics Inc 2017 54.330000 110.0000 USD 1
AGIO Agios Pharmaceuticals Inc 2017 46.380000 82.5000 USD 2
SRPT Sarepta Therapeutics Inc 2017 28.270000 82.0000 USD 3
GBT Global Blood Therapeutics Inc 2017 22.400000 60.0000 USD 2
ATRA Atara Biotherapeutics Inc 2017 15.750000 47.0000 USD 1

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

GOOG:NAS Alphabet

https://www.abc.xyz
Alphabet has 72053 employees and is headquartered in United States.
Alphabet Inc through its subsidiary Google Inc is engaged in improving the ways people connect with information & products including Search, Android, YouTube, Apps, Maps & Ads. It also produces internet-connected home devices & provides internet services.

GILD:NAS Gilead Sciences

http://www.gilead.com
Gilead Sciences has 8000 employees and is headquartered in United States.
Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

NVIDIA (NVDA:NAS) and CSX (CSX:NAS) Upgraded

I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Upgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been upgraded by at least one analyst in the last few days.

Why Do Companies Get Upgraded?

Companies can get upgraded for a number of reasons, but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
WPZ Williams Partners LP 3 0 1 1 0 0 4.0000 3.7500 Outperform
CI Cigna Corp 3 0 1 1 0 0 4.0000 3.6000 Outperform
MAS Masco Corp 5 0 4 0 0 0 4.1111 4.0000 Outperform
CPN Calpine Corp 5 0 2 0 0 0 4.4286 4.2857 Outperform
RLGY Realogy Holdings Corp 2 0 1 0 0 0 4.3333 3.6667 Outperform
DNB Dun & Bradstreet Corp 0 0 1 0 0 0 3.0000 2.0000 Hold
ERF Enerplus Corp 7 3 2 0 0 0 4.4167 4.2500 Outperform
DF Dean Foods Co 1 0 2 0 0 0 3.6667 3.0000 Outperform
FIT Fitbit Inc 1 0 3 0 0 0 3.5000 3.0000 Hold
FGP Ferrellgas Partners LP 0 0 1 0 1 0 2.0000 1.0000 Underperform
BCRH Blue Capital Reinsurance Holdings Ltd 1 0 0 0 1 0 3.0000 1.0000 Hold
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
TIH Toromont Industries Ltd 0 2 7 0 0 0 3.2222 3.1250 Hold
ERF Enerplus Corp 7 3 2 0 0 0 4.4167 4.2500 Outperform
MEG MEG Energy Corp 0 4 4 0 0 0 3.5000 3.3750 Hold
SW Sierra Wireless Inc 3 2 4 0 1 0 3.6000 3.4000 Outperform
TDG Trinidad Drilling Ltd 5 4 3 0 1 0 3.9231 3.9167 Outperform
CUS Canexus Corp 0 0 2 0 2 0 2.0000 1.8000 Underperform
VCM Vecima Networks Inc 1 0 1 0 0 0 4.0000 3.0000 Outperform
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
NVDA NVIDIA Corp 5 0 4 0 1 0 3.8000 3.6000 Outperform
CSX CSX Corp 4 0 7 0 0 0 3.7273 3.5455 Outperform
EXPE Expedia Inc 6 1 1 0 0 0 4.6250 4.5000 Buy
SWIR Sierra Wireless Inc 3 2 4 0 1 0 3.6000 3.4000 Outperform

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

NVDA:NAS NVIDIA

http://www.nvidia.com
NVIDIA has 9227 employees and is headquartered in United States.
NVIDIA Corp is a visual computing company targeting markets including Gaming, Professional Visualization, Datacenter and Automotive. The Company’s reporting segments include GPU and Tegra Processor.

CSX:NAS CSX

http://www.csx.com
CSX has 29410 employees and is headquartered in United States.
CSX Corp is a freight rail transportation company. The Company provides rail-based transportation services including traditional rail service and the transport of intermodal containers and trailers.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.